Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Aker BioMarine ASA ( (DE:1PG) ) just unveiled an announcement.
Trond Atle Smedsrud, CEO of Emerging Businesses at Aker BioMarine ASA, recently acquired 6,500 shares in the company through his investment firm HAWI Holding AS, at an average price of NOK 85.72 per share. This transaction, which took place on the Oslo Børs, increases Smedsrud’s total holdings to 19,789 shares, reflecting a significant personal investment in the company and potentially signaling confidence in Aker BioMarine’s market position and future prospects.
More about Aker BioMarine ASA
Aker BioMarine is a leading innovator in human health and nutrition, specializing in krill and algae-derived products. The company’s portfolio includes Superba Krill Oil, Lysoveta, FloraMarine, and PL+, along with the consumer brand Kori Krill. Aker BioMarine also ventures into sustainability with its spin-offs AION and Understory, focusing on plastic waste reduction and protein products, respectively. The company is listed on the Oslo Stock Exchange.
Average Trading Volume: 23,990
Current Market Cap: NOK7.32B
See more data about 1PG stock on TipRanks’ Stock Analysis page.